MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, GLUE made $123,672K in revenue. -$39,097K in net income. Net profit margin of -31.61%.

Income Overview

Revenue
$123,672K
Net Income
-$39,097K
Net Profit Margin
-31.61%
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Collaboration revenue
123,672
Research and development
141,500
General and administrative
36,380
Total operating expenses
177,880
Loss from operations
-54,208
Interest income
12,942
Foreign currency exchange gain, net
1,484
Gain on disposal of fixed assets
59
Total other income
14,485
Net loss before income taxes
-39,723
Income tax benefit (provision)
-1,097
Net loss
-38,626
Provision for pension benefit obligation
-518
Unrealized gain on available-for-sale securities
-47
Comprehensive loss
-39,097
Basic Average Shares
83,071,185
Diluted Average Shares
83,071,185
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$39,097K Unrealized gain onavailable-for-sale securities-$47K Net loss-$38,626K Provision for pensionbenefit obligation-$518K Income tax benefit(provision)-$1,097K Interest income$12,942K Foreign currencyexchange gain, net$1,484K Gain on disposal offixed assets$59K Net loss beforeincome taxes-$39,723K Total other income$14,485K Loss from operations-$54,208K Collaboration revenue$123,672K Total operatingexpenses$177,880K Research and development$141,500K General andadministrative$36,380K

Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics, Inc. (GLUE)